Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?
about
Parallel Aspects of the Microenvironment in Cancer and Autoimmune DiseaseEnigma of IL-17 and Th17 Cells in Rheumatoid Arthritis and in Autoimmune Animal Models of ArthritisHuman genome-wide expression analysis reorients the study of inflammatory mediators and biomechanics in osteoarthritisPresence of IL-17 in synovial fluid identifies a potential inflammatory osteoarthritic phenotype.First-in-human randomized study of bimekizumab, a humanized monoclonal antibody and selective dual inhibitor of IL-17A and IL-17F, in mild psoriasisInfection of Interleukin 17 Receptor A-Deficient C3H Mice with Borrelia burgdorferi Does Not Affect Their Development of Lyme Arthritis and Carditis.Correlation of IL-17 Level in Synovia and Severity of Knee Osteoarthritis.Neutrophils Do Not Express IL-17A in the Context of Acute Oropharyngeal Candidiasis.Lymph node biopsy analysis reveals an altered immunoregulatory balance already during the at-risk phase of autoantibody positive rheumatoid arthritis.The IL-23-IL-17 axis in inflammatory arthritis.Altered immunoregulation in rheumatoid arthritis: the role of regulatory T cells and proinflammatory Th17 cells and therapeutic implications.Progress in understanding and utilizing TNF-α inhibition for the treatment of psoriatic arthritis.Anti-IL-17 therapy in treatment of rheumatoid arthritis: a systematic literature review and meta-analysis of randomized controlled trials.Psoriatic arthritis and psoriasis: differential diagnosis.Secukinumab: A Review in Psoriatic Arthritis.The role of IL 23 in the treatment of psoriasis.Quantitative imaging by pixel-based contrast-enhanced ultrasound reveals a linear relationship between synovial vascular perfusion and the recruitment of pathogenic IL-17A-F+IL-23+ CD161+ CD4+ T helper cells in psoriatic arthritis joints.Synovial membrane receptors as therapeutic targets: A review of receptor localization, structure, and function.A Truncated IL-17RC Peptide Ameliorates Synovitis and Bone Destruction of Arthritic Mice.Follistatin-like protein 1 modulates IL-17 signaling via IL-17RC regulation in stromal cells.Peripheral Ulcerative Keratitis Associated with Autoimmune Disease: Pathogenesis and Treatment.The impact of age and gut microbiota on Th17 and Tfh cells in K/BxN autoimmune arthritis.Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation.Psoriasis pathogenesis and the development of novel targeted immune therapies.Interleukin-17 and Toll-like Receptor 10 genetic polymorphisms and susceptibility to large joint osteoarthritis.Secukinumab in Active Rheumatoid Arthritis: A Phase III Randomized, Double-Blind, Active Comparator- and Placebo-Controlled Study.The role of IL-23 receptor signaling in inflammation-mediated erosive autoimmune arthritis and bone remodeling.Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints.Interleukin-17 in skin: psoriasis and yonder.Characterization of IL-17AA and IL-17FF in rheumatoid arthritis and multiple sclerosis.Fraxinellone Attenuates Rheumatoid Inflammation in Mice.A Reappraisal on the Potential Ability of Human Neutrophils to Express and Produce IL-17 Family Members In Vitro: Failure to Reproducibly Detect It.[Psoriatic arthritis : Drugs of the (near) future].Plasma miR-136 can be used to screen patients with knee osteoarthritis from healthy controls by targeting IL-17
P2860
Q26753174-9BE8281E-80DA-4C59-8B51-D257DF751DE7Q26768254-E0BE619B-152A-4AA0-8FDC-EBAB086933A4Q28085065-08AFEDCA-686E-41E0-B858-6D485CF96209Q33553954-89D3AD7C-CECE-4C44-947F-AD4C543A67E2Q33593625-385BB26B-D151-4B97-94AC-AFCBED6B1514Q35745610-F56888F9-657E-4835-9112-C7B06FBCDBF6Q35779257-370DEF76-613D-4726-811A-09A8BB24E81CQ36096377-04C8C899-F9A8-4606-9F13-1DACD3023619Q37505439-DA37E1E7-4F00-43FE-BE05-2D5D1F709B7AQ38439641-5E8720D3-AE73-42E0-BA70-F8E175F31BB3Q38445764-52E75DEA-E008-4135-B907-33E252BA9DB9Q38630548-E096CDF6-EEB9-407E-83F5-1B6D33739111Q38815234-1BBAF516-F09B-40C0-88CD-3C5CD60E6369Q38828427-CBB09A39-BB62-46BD-9282-9CC486BF7E1BQ38864743-8E1B8E46-8710-4004-B522-EB1FCE749A42Q38976762-A284BBCD-E66B-463A-A8D5-BED1ACFCE14AQ39084926-43AB0D7C-CCA0-4F7F-8A26-5DE1C88EFFC4Q39218577-802174A4-BB2F-43D1-B9F1-BB8F0A0FFC6EQ39317301-0E0E018A-E02E-4505-9429-A082961023B0Q40264549-F313D4D0-01B4-4C91-BD1F-326A387E696BQ41146632-5E480756-E22F-48C5-BEC0-68FBD0E4690CQ41431084-5B32CE54-45D6-41FF-8336-AEE84E133AE3Q47253021-11352370-B3E3-416F-8BF9-7CE75338A6A2Q47830025-1978A0C0-5EF4-4F51-93FC-2190D37B08E0Q48196941-D3F0A314-2112-4603-97E8-297E4BAD924AQ48219239-C13A3E7A-61E5-4F33-8E89-BA8630D3F607Q48283709-71EA4359-68EA-497B-9A50-683DDFBE878EQ50099588-9D6D2E7D-C235-4182-B72B-2279EDD4EBA6Q51358143-5914EA5D-D649-4407-B126-DD96827BD51BQ51515919-707B9DB5-D19F-43A4-8753-97714F828C14Q52658060-14AB1F5B-96ED-4E9E-AAEE-D48247DA48AAQ54987441-2C738B3E-4103-4DE3-826A-196D21591D02Q54998108-45FB6729-84D5-43CC-BBB0-B00E1BBBCCE1Q58733386-EB324F5C-0E07-4CB4-8D68-24FDB219B7C5
P2860
Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Heterogeneous expression patte ...... esponse to anti-IL-17 therapy?
@ast
Heterogeneous expression patte ...... esponse to anti-IL-17 therapy?
@en
Heterogeneous expression patte ...... esponse to anti-IL-17 therapy?
@nl
type
label
Heterogeneous expression patte ...... esponse to anti-IL-17 therapy?
@ast
Heterogeneous expression patte ...... esponse to anti-IL-17 therapy?
@en
Heterogeneous expression patte ...... esponse to anti-IL-17 therapy?
@nl
prefLabel
Heterogeneous expression patte ...... esponse to anti-IL-17 therapy?
@ast
Heterogeneous expression patte ...... esponse to anti-IL-17 therapy?
@en
Heterogeneous expression patte ...... esponse to anti-IL-17 therapy?
@nl
P2093
P2860
P1476
Heterogeneous expression patte ...... esponse to anti-IL-17 therapy?
@en
P2093
Daniëlle M Gerlag
Dennis van der Coelen
Man W Tang
Maria C Lebre
Paul P Tak
Saïda Aarrass
Tamara H Ramwadhdoebe
P2860
P2888
P356
10.1186/S13075-014-0426-Z
P577
2014-08-22T00:00:00Z
P5875
P6179
1035795517